VBL Therapeutics Appoints Alison Finger and Michael Rice to its Board of Directors
Retrieved on:
Thursday, July 8, 2021
TEL AVIV, Israel, July 08, 2021 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT) today announced the appointments of Alison Finger and Michael Rice to its Board of Directors, effective July 7, 2021.
Key Points:
- TEL AVIV, Israel, July 08, 2021 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT) today announced the appointments of Alison Finger and Michael Rice to its Board of Directors, effective July 7, 2021.
- Professor Ruth Arnon has stepped down from her role as a member of VBLs Board of Directors, effective July 6, 2021.
- She will continue her engagement with VBL as a scientific consultant and a member of its Scientific Advisory Board.
- We are pleased to welcome Alison and Michael as the newest members of our Board of Directors, said Bennett Shapiro, M.D., Chairman of VBLs Board of Directors.